Skip to content
+1-516-222-6222
LCS@lachmanconsultants.com
Search
  • About
    • Lachman Leadership Team
  • Areas Served
    • Pharmaceutical
    • Medical Device & Combination Products
    • Biologics
    • Regulatory Affairs
  • Services
    • Compliance
    • Data Integrity
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • FDA-Related Services
    • FDA 483 Response
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Virtual Inspections
    • Remote Services From Lachman
  • Markets
    • Pharmaceuticals
    • Medical Devices
    • Combination Products
    • Biotechnology
    • Biologics
    • Diagnostics
    • Generics
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    • Career Opportunities
  • Resources
    • Lachman Learning

Omicron

Lachman Consultant Services, Inc. / Blog / Omicron
08
Dec

COVID-19 Variant Mutations Could Impact Test Results

By Bob Pollock    Dec 08, 2021    COVID-19 Omicron Testing

Yesterday, the FDA published a document (here) detailing potential impact on the performance of specific COVID-19 detection tests for the Omicron variant as well as other variants of SARS-CoV-2.  The FDA listed tests that may have reduced ability to detect the SARS-CoV-2 Omicron variant and provided a list of thirty‑three sites at which this test […]

Read More

Subscribe to our blog

Recent Articles

  • FDA Provides Annual Forecast Activities for Various OTC Monographs -Some Surprises Here!
  • FY 2024 May Be the Year to Jump on the Savings for Use of Priority Review Voucher
  • Mullin and Booker Introduce Bill for e-labeling – New Round Begins

Contact Us:



Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.
+1-516-222-6222
LCS@lachmanconsultants.com

 

Subscribe to our blog

Quick Links

  • Home
  • About
  • Services
  • Areas Served
  • Markets
  • Careers
  • Blog
  • Contact
  • Intranet

Recent Posts

  • FDA Provides Annual Forecast Activities for Various OTC Monographs -Some Surprises Here_LachmanConsultantsFDA Provides Annual Forecast Activities for Variou…
    September 29, 2023
  • Mullin and Booker Introduce Bill for e-labeling &#…
    September 27, 2023
  • Lachman Consultants to Participate at This Year’s …
    September 25, 2023
2023 © Lachman Consultant Services, Inc.Terms and ConditionsPrivacy Policy
  • About
    ▼
    • Lachman Leadership Team
  • Areas Served
    ▼
    • Pharmaceutical
    • Medical Device & Combination Products
    • Biologics
    • Regulatory Affairs
  • Services
    ▼
    • Compliance
    • Data Integrity
    • Analytical Services
    • Biomonitoring Support
    • Strategic Planning
    • FDA-Related Services
    • FDA 483 Response
    • Due Diligence Audits
    • Quality Assurance and Controls
    • Scientific and Technical Assistance
    • Systems Evaluation
    • Facilities Design or Validation
    • System Process Validation or Qualification
    • Training
    • Virtual Inspections
    • Remote Services From Lachman
  • Markets
    ▼
    • Pharmaceuticals
    • Medical Devices
    • Combination Products
    • Biotechnology
    • Biologics
    • Diagnostics
    • Generics
    • Related Industries
  • Blog
  • News
  • Contact
  • Careers
    ▼
    • Career Opportunities
  • Resources
    ▼
    • Lachman Learning